News
Travere Therapeutics, Inc., today announced that the Company will present three abstracts on the effect of FILSPARI (sparsentan) in rare kidney disease at the upcoming International Podocyte ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback